StockVS

Sharps Technology, Inc. (STSS) 股票分析

医疗保健

Sharps Technology, Inc.

$1.82

+$0.01 (+0.55%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Sharps Technology, Inc. operates as a specialized provider within the healthcare sector, specifically focusing on the medical instruments and supplies industry. The company's core business involves manufacturing and distributing smart-safety syringe products designed to integrate advanced waste disposal capabilities directly into syringe technologies for the healthcare industry. In terms of scale, the company holds a market capitalization of $63.02 million and reports trailing twelve-month revenue of $204,120. Although the exact employee count is not disclosed in available records, the disparity between its revenue figure and market cap suggests a capital structure that is heavily influenced by market sentiment rather than traditional sales volume metrics. This valuation indicates that the market is pricing the stock based on its strategic positioning in the medical device space and its unique digital asset treasury strategy, rather than current operational profitability or revenue generation capacity.

财务健康

The financial statements for Sharps Technology, Inc. reveal a complex operational reality where trailing twelve-month revenue stands at $204,120, while net income for the same period is a significant loss of $-270,335,424, and EBITDA is recorded at $-13,159,940. The substantial gap between the relatively low revenue of $204,120 and the massive negative net income of $-270,335,424 indicates a severe cost structure issue, where expenses far exceed total sales, resulting in a loss that dwarfs the top-line performance. Despite the negative earnings, the company reports a free cash flow of $93.85 million, which suggests a degree of financial flexibility potentially derived from asset sales or the liquidation of reserves rather than operational cash generation. Analyzing the margins further, the gross margin is listed at -202.5%, the operating margin is -6512.1%, and the profit margin is 0.0%, all of which indicate that the company is currently unable to cover its direct costs or operating expenses with its current revenue stream. Regarding the balance sheet, the company holds $10.38 million in cash against $3.08 million in debt, resulting in a debt-to-equity ratio of 1.17, which implies a leveraged position where liabilities slightly exceed equity despite the high cash balance. The current ratio stands at 4.02, indicating that the company possesses 4.02 times the liquid assets necessary to cover its short-term liabilities, pointing to strong short-term liquidity on paper. Finally, the return on equity is -203.0% and the return on assets is -6.0%, metrics that reveal management is currently unable to generate positive returns on the capital invested or the assets employed by the business.

估值评估

Valuation metrics for Sharps Technology, Inc. present a distorted picture due to the company's lack of positive earnings, with the P/E ratio (TTM) listed as N/A and the forward P/E at -10.87. The difference between the non-existent trailing P/E and the negative forward P/E implies that future earnings are not expected to be positive enough to support a traditional multiple, reflecting the uncertainty of the earnings trajectory. The price-to-book ratio is 0.10, indicating that the stock is trading at a significant discount to its book value, which often suggests a distressed valuation or market skepticism regarding the asset quality. Alternative valuation metrics such as the price-to-sales ratio of 308.76 and an EV/EBITDA of -4.23 suggest that the market is pricing the stock based on speculative potential or non-operating factors rather than current sales efficiency or earnings power. The 52-week trading range spans from a low of $1.42 to a high of $18.23, and given the forward P/E and current market dynamics, the current price sits within a highly volatile range defined by these extremes. The beta value of 2.07 indicates that the stock's price volatility is more than double that of the broader market, meaning the asset experiences extreme price swings relative to general market movements.

Growth & Income

Growth metrics for Sharps Technology, Inc. show revenue growth year-over-year as N/A and earnings growth year-over-year as N/A, which prevents a direct comparison of earnings growth rates relative to revenue expansion. Since the company does not pay dividends, the dividend yield is N/A and the payout ratio is 0.0%, meaning the company reinvests its earnings—or in this case, utilizes its cash reserves—to fund operations rather than distributing income to shareholders. The overall growth and income profile is characterized by a lack of historical growth data and a complete absence of dividend income, relying entirely on capital appreciation potential driven by the company's unique treasury strategy and market positioning. This profile suggests that the investment thesis relies on future structural changes in the company's cost structure or revenue model rather than consistent income generation or historical growth acceleration.

同行比较

Sharps Technology, Inc. (STSS) 在医疗器械与用品行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Sharps Technology, Inc. STSS $77.03M N/A
Intuitive Surgical, Inc. ISRG $154.64B 53.2
Becton, Dickinson and Company BDX $40.71B 25.8
Alcon Inc. ALC $33.02B 40.5

医疗器械与用品行业平均市盈率为208.0倍。Sharps Technology, Inc.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Sharps Technology, Inc.

Sharps Technology, Inc. engages in the marketing and distribution of syringe products and related drug-delivery systems in the United States and internationally. The company operates in two segments, Medical Device Packaging and Digital Asset Treasury. It distributes and markets safety syringes under the SecureGard, SoloGard, and Provensa brands; prefillable polymer syringes; and pharmaceutical services. The company also engages in executing and managing its treasury platform, which focuses on accumulating Solana. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

公司简介以英文显示。

访问官网 →

关键指标

市值
$77.03M
市盈率
N/A
52周最高
$18.23
52周最低
$1.42
平均成交量
316.56K
Beta系数
2.02

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States